Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BRIDGE: Anakinra for Donor Graft Edema Reduction in Lung Transplant
NCT07410312Phase 1Not yet recruiting
- Sponsor
- Northwestern University
- Start
- Oct 2026
- Primary completion
- Aug 2027
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
Phase 1, randomised trial of anakinra in primary graft dysfunction (PGD) (2 arms), sponsored by Northwestern University. Primary endpoint: Primary graft dysfunction after lung transplant at 3 days. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
anakinra
03
Conditions
primary graft dysfunction (PGD)
Beyond the preview
Go deeper on NCT07410312.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07410312.